Bischoff, Stephan C.León Sanz, Miguel Francisco JoséCuerda Compes, María Cristina2024-01-152024-01-152022-10-14Bischoff SC, Barazzoni R, Busetto L, et al. European guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline. Clin Nutr. 2022;41(10):2364-2405.0261-561410.1016/j.clnu.2022.07.003https://hdl.handle.net/20.500.14352/93112La European Society of Clinical Nutrition and Metabolism (ESPEN) es una importante sociedad científica global, con 70 Sociedades Científicas nacionales federadas, de todos los continentes. Sus Guías de Práctica Clínica son una referencia a nivel mundial para la atención de los pacientes. Formar parte del equipo que elabora las Guías es un reconocimiento como experto. Los autores se repartieron las preguntas PICO para la localización y revisión de la evidencia publicada, elaborar el texto y definir las recomendaciones relacionadas con estas preguntas PICO. Hubo dos reuniones plenarias en las que se revisaban todas las recomendaciones y textos acompañantes, y se votaban. Finalmente, se escribía la versión final. Desde la publicación de esta Guía ha recibido 26 citaciones.Background: Patients with chronic gastrointestinal (GI) disease such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), celiac disease, gastroesophageal reflux disease (GERD), pancreatitis, and chronic liver disease (CLD) often suffer from obesity because of coincidence (IBD, IBS, celiac disease) or related pathophysiology (GERD, pancreatitis and CLD). It is unclear if such patients need a particular diagnostic and treatment that differs from the needs of lean GI patients. The present guideline addresses this question according to current knowledge and evidence. Objective: The objective of the guideline is to give advice to all professionals working in the field of gastroenterology care including physicians, surgeons, dietitians and others how to handle patients with GI disease and obesity. Methods: The present guideline was developed according to the standard operating procedure for ESPEN guidelines, following the Scottish Intercollegiate Guidelines Network (SIGN) grading system (A, B, 0, and good practice point (GPP)). The procedure included an online voting (Delphi) and a final consensus conference. Results: In 100 recommendations (3x A, 33x B, 24x 0, 40x GPP, all with a consensus grade of 90% or more) care of GI patients with obesity - including sarcopenic obesity - is addressed in a multidisciplinary way. A particular emphasis is on CLD, especially fatty liver disease, since such diseases are closely related to obesity, whereas liver cirrhosis is rather associated with sarcopenic obesity. A special chapter is dedicated to obesity care in patients undergoing bariatric surgery. The guideline focuses on adults, not on children, for whom data are scarce. Whether some of the recommendations apply to children must be left to the judgment of the experienced pediatrician. Conclusion: The present guideline offers for the first time evidence-based advice how to care for patients with chronic GI diseases and concomitant obesity, an increasingly frequent constellation in clinical practice.engAttribution-NonCommercial-NoDerivatives 4.0 Internationaljournal articlehttps://www.journals.elsevier.com/clinical-nutritionhttps://pubmed.ncbi.nlm.nih.gov/35970666/open access616.3Bariatric surgeryInflammatory bowel diseaseNon-alcoholic fatty liver diseaseObesitySarcopenic obesityCiencias Biomédicas32 Ciencias Médicas